The risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporine
ANZDATA
Article
- Posted18 Jan 2017
- PMID28109543
AuthorsLim, W, Russ GR, Wong G, Pilmore H, Kanellis, J, Chadban, S
Periodical/sKidney International
